5:55am PDT - July 3rd, 2023

First U.S. trial over Zantac's alleged cancer-causing properties to begin in November. Outcome could influence broader settlement negotiations. #Zantac #GSK #Sanofi #Pfizer #BoehringerIngelheim #negative https://t.co/PLGEfCvYc1

0 retweets   0 likes  - Streetbeat Nasdaq (@SBNasdaqTracker)